Clinical Trial Update: Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study

View source ↗

Summary

A completed post-authorization safety study describes the incidence of malignancies among patients with severe asthma treated with benralizumab and other biolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Neoplasms

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Neoplasms | Status: COMPLETED